introduction chronic right ventricular pacing sometimes lead deterioration left ventricular ejection fraction lvef pacing provokes interventricular dyssynchrony intraventricular dyssynchronous contraction left ventricle combination electrical mechanical dyssynchrony lead adverse remodeling promotes heart failure atrial fibrillation mortality deterioration systolic function related pacemaker implantation pmi termed pacemaker-induced cardiomyopathy picm previous study used different lvef threshold define picm therefore currently internationally accepted definition picm following three definition picm used past clinical study lvef baseline lvef absolute reduction lvef baseline lvef baseline lvef absolute reduction lvef baseline absolute reduction lvef regardless baseline function wide variation published prevalence development picm 5–27 highest prevalence reported according definition absolute reduction lvef follow-up 3–4 year furthermore worldwide survey showed number patient undergoing pmi increased therefore number patient picm also increased identifying risk factor picm pmi beneficial preventing picm-associated heart disease reported older age male sex history myocardial infarction lower baseline lvef wider intrinsic qrs duration left bundle branch block lbbb history chronic higher pacing burden could risk factor picm however precise mechanism established risk factor picm fully identified therefore present study aimed identify additional risk factor picm method definition picm study picm defined follows exclusion alternative cause heart disease acute myocardial ischemia uncontrollable tachyarrhythmia frequent premature contraction untreated hypertension absolute reduction lvef measured transthoracic echocardiography tte pmi compared pmi tte data collected within six month pmi three month three year pmi tte data over-read cardiovascular expert data collection study population data retrospectively acquired university tokyo hospital tokyo japan patient underwent novo pmi december november pmi performed patient sick sinus syndrome atrioventricular block avb total patient undergoing pmi included study identify risk factor picm medical history clinical data retrospectively collected patient flow data collection study shown fig figure flowchart data collection study population patient underwent novo pacemaker implantation studied december november among patient matched criterion enrolled tte transthoracic echocardiogram picm pacing-induced cardiomyopathy full size image inclusion criterion follows age year novo pmi available data tte pmi exclusion criterion follows implantation prior cardiac implantable electronic device lack tte and/or pmi congenital heart disease heart transplantation alternative cause reduction lvef acute myocardial ischemia valvular heart disease uncontrollable tachyarrhythmia frequent premature contraction untreated hypertension addition patient laboratory data obtained upon admission hospital follow-up lvef examination discharge clinical outcome definition clinical variable primary outcome incidence reduced ejection fraction defined reduction lvef follow-up tte pmi new york heart association nyha class categorized basis symptom evaluation medical examination admission expert cardiologist diagnosed electrocardiogram admission diabetes mellitus diagnosed glycated hemoglobin value 6.5 determined history taking oral hypoglycemic agent insulin injection hypertension diagnosed systolic blood pressure mmhg diastolic blood pressure mmhg history antihypertensive agent also used determine estimated glomerular filtration rate egfr calculated serum creatinine −1.094 age −0.287 0.739 female patient chronic kidney disease ckd defined egfr ml/min/1.73 statistical analysis patient divided two group picm group non-picm group basis definition picm previously described difference baseline characteristic compared two group student -test mann–whitney test continuous variable chi-square test categorical variable appropriate incidence rate picm confidence interval calculated person-years assumption poisson distribution total patient cumulative rate picm calculated kaplan–meier method time-to-event data shown kaplan–meier curve cox univariate multivariate analysis performed estimate hazard ratio clinical variable developing picm statistical analysis performed using ibm spss version 28.0.0.0 ibm corp. armonk two-tailed value 0.05 indicated statistical significance ethical approval study approved university tokyo institutional ethic committee approval number 2650- patient information deidentified requirement written informed consent waived university tokyo institutional ethic committee study protocol conducted accordance declaration helsinki result clinical procedural characteristic one hundred thirteen patient underwent novo pmi tte data pmi enrolled patient characteristic shown table mean age 71.3 11.2 year old range 25–91 year mean lvef pmi 65.0 13.0 mean egfr pmi 59.3 24.8 ml/min/1.73 patient underwent implantation dual-chamber pacemaker 68.1 underwent pmi 31.9 avb patient diagnosed atrioventricular block avb following classification observed patient 72.2 exhibited complete avb six patient representing 16.7 2:1 avb remaining four patient accounting 11.1 diagnosed advanced avb table characteristic patient full size table among enrolled patient 38.9 medical history coronary artery disease cad 29.2 patient undergone percutaneous coronary intervention pci patient picm group prevalent medical history cad 54.5 vs. 32.5 0.03 history previous pci 42.4 vs. 29.2 0.05 lower egfr 50.9 25.2 ml/min/1.73 vs. 62.7 23.9 ml/min/1.73 0.02 higher rate egfr ml/min/1.73 24.2 vs. 6.3 0.01 lower rate lbbb vs. 12.5 0.03 shorter qrs duration 105.2 19.1 vs. 116.9 25.6 0.02 non-picm group significant difference background factor two group supplementary table outline position lead tip distribution lead tip across various region follows apex patient 28.3 septum patient 61.9 left bundle area patient 2.7 bundle area patient 7.1 noteworthy significant disparity frequency lead placement apex patient diagnosed picm without right atrial pacing frequency patient picm non-picm group pmi investigated retrospectively pacemaker interrogation data obtained closest date tte examination significant difference pacing frequency two group table table right atrial right ventricular pacing frequency full size table prevalence picm mean follow-up 1.6 0.9 year 29.2 patient developed picm incidence rate 18.0/100 person-years 12.8–25.2 total follow-up person-years kaplan–meier curve rate developing picm shown fig rate evaluated log-rank test determining difference patient without ckd addition patient divided four group egfr follows egfr ml/min/1.73 egfr ml/min/1.73 ml/min/1.73 egfr ml/min/1.73 ml/min/1.73 egfr ml/min/1.73 significant difference incidence picm four group egfr log-rank 0.03 additionally marked difference incidence picm group well group log-rank value 0.02 0.01 respectively finding detailed table remarkably patient egfr ml/min/1.73 showed higher incidence picm egfr ml/min/1.73 figure incidence picm patient chronic kidney disease kaplan–meier curve shown development picm year follow-up egfr categorized four group egfr ml/min/1.73 egfr ml/min/1.73 ml/min/1.73 egfr ml/min/1.73 ml/min/1.73 egfr ml/min/1.73 significant difference incidence picm among four group detected picm pacing-induced cardiomyopathy egfr estimated glomerular filtration rate ml/min/1.73 full size image figure incidence picm patient ckd egfr ml/min/1.73 kaplan–meier curve shown development picm log-rank test used comparing patient without ckd significant difference incidence developing picm two group picm pacing-induced cardiomyopathy ckd chronic kidney disease full size image table log-rank analysis incidence pacemaker-induced cardiomyopathy based renal function status full size table risk factor picm univariate cox regression analysis clinical feature associated prediction picm performed table every ml/min/1.73 decrease egfr 1.19 1.01–1.40 egfr ml/min/1.73 3.47 1.48–8.16 medical history cad 2.76 1.36–5.60 significantly related development picm however neither lbbb every 10-ms prolongation qrs duration significantly associated picm 0.86 0.73–1.01 1.19 1.01–1.40 respectively table univariate cox model hazard ratio pacemaker-induced cardiomyopathy full size table adjusting every 10-ms prolongation qrs duration egfr ml/min/1.73 medical history cad multivariate cox regression analysis showed egfr ml/min/1.73 cad significant independent risk factor picm 2.62 1.09–6.29 2.32 1.13–4.80 respectively fig figure forest plot hazard ratio picm according multivariate analysis cox model adjusting qrs duration egfr cad multivariate cox regression analysis showed egfr ml/min/1.73 cad independent risk factor developing picm confidence interval hazard ratio egfr estimated glomerular filtration rate cad coronary artery disease full size image discussion previous study reported older age male sex history myocardial infarction lower baseline lvef wider intrinsic qrs duration lbbb history chronic higher pacing burden could risk factor picm however variable medical history cad risk factor picm analysis although general opinion pacing burden detrimental effect left ventricular function present study revealed higher proportion patient underwent pmi rather avb picm group table additionally difference percentage pacing patient picm picm table recently reported significant difference development severe dysfunction observed among patient avb large cohort pacemaker recipient normal lvef sanchez showed developing associated pacing mode ventricular lead localization patient finding suggested picm could developed patient regardless pacing burden patient picm prevalent medical history cad lower egfr without picm study multivariate cox hazard model analysis also showed medical history cad stage 4–5 ckd defined egfr ml/min/1.73 significant risk factor associated picm result indicated medical history cad could independent risk factor picm past study reported tayal reported pmi patient antecedent history ckd increased risk however previous study reported association renal dysfunction picm best knowledge study first report show egfr ml/min/1.73 independent risk factor picm frequency picm reported 5.1–26.8 follow-up mean period 1–15 year incidence rate picm study 29.2 mean 1.6 year follow-up slightly higher many previous study however previous study reported prevalence picm according definition study point view difference incidence current study could explained high prevalence severe ckd egfr ml/min/1.73 patient picm word total 11.5 patient low gfr ml/min/1.73 renal impairment confers high risk poor cardiovascular outcome increasing mortality patient particular moderate/severe renal impairment high risk developing various mechanistic insight proposed finding renal impairment upregulate renin–angiotensin–aldosterone system enhance basal sympathetic nerve discharge increasing pro-inflammatory factor oxidative stress additionally endothelial dysfunction exacerbation underlying anemia worsening hypertrophy myocyte contractility related incidence impairment ventricular systolic function high phosphorus status associated ckd also promotes calcification cardiac vessel valve accelerating reduced lvef atherosclerosis ckd affect cardiac function interaction worsens metabolic causality also reported cause picm several study proposed pacing induce abnormal myocardial metabolism altered regional perfusion increase fibrosis cause myofibrillar disarray however possibility still proven recently lin suggested mechanism picm intracellular lipid accumulation induced pacing increase fibrosis myocardium animal model including pig rat addition showed inhibition liver receptor/retinoid receptor pathway regulates lipid metabolism inflammation cholesterol bile acid catabolism associated pacing moreover lipid-lowering pleiotropic effect treatment statin attributed preventing picm reducing hospitalization cardiovascular death all-cause mortality patient avb result suggest causative role lipid accumulation picm even non-pacemaker-implanted patient patient diabetes mellitus obesity abnormal intramyocardial lipid accumulation frequently observed owing metabolic change heart addition cardiac lipid accumulation positively correlated cardiac dysfunction called lipotoxic cardiomyopathy taking finding consideration believe cardiac metabolic modulation due pacing play important role impairment cardiac function result could help identify patient develop picm pmi severe renal dysfunction history cad could independent risk factor picm therefore patient risk factor require closer follow-up tte avoid missing appropriate timing upgrading cardiac resynchronization therapy furthermore conduction system pacing his-bundle pacing left-bundle pacing alternative option patient avb high-risk factor undergo pmi limitation study limitation first retrospective study single center comparatively small number participant reflect direct causation second measurement tte performed among patient pacemaker time window performing follow-up tte unclear observational period occurrence picm long term medium term instead third pmi procedure current study likely included older material method data lacked information lead tip position finally study regarding effect cad ckd incidence picm pmi required confirm finding conclusion past medical history cad severe stage ckd stage pmi newly discovered risk factor picm therefore intensive follow-up required detect deterioration lvef early stage